Hutch News

Hutch News

Stories tagged 'biologics'

Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


Biologics and biosimilars step onto the cancer therapy stage

Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?

May 31, 2018 | By Diane Mapes / Fred Hutch News Service

Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.